{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:37:06Z","timestamp":1788565026703,"version":"build-2803163510"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical &amp; Translational All"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Although patients with chronic rhinosinusitis with nasal polyps (CRSwNP) may benefit from endoscopic sinus surgery (ESS), some patients will experience polyp recurrence, adding to the overall disease burden of CRSwNP. We aimed to investigate predictors of revision ESS in patients with CRSwNP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A nationwide population\u2010based study including all adults diagnosed with CRSwNP who had surgical procedure codes for ESS (<jats:italic>N<\/jats:italic>\u00a0=\u00a03506), followed up between January 2012 and December 2019. Logistic regression models provided adjusted odds ratios (OR) with 95% confidence intervals (CIs) for the odds of revision surgery within one and 3\u00a0years post\u2010index surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>559 (15.9%) of the patients had at least one revision surgery during the follow\u2010up. Median time to revision of ESS was 425\u00a0days (interquartile range: 213\u2013898). Baseline asthma (OR\u00a0=\u00a01.58, 95% CI 1.17\u20132.12) and antibiotic use (OR\u00a0=\u00a01.61, 95% CI 1.27\u20132.04) were associated with higher odds of revision ESS, particularly within 3\u00a0years post\u2010index surgery, whereas Increasing age was inversely associated with the odds of ESS revision (OR\u00a0=\u00a00.82, 95% CI 0.76\u20130.88). The highest odds of revision ESS were observed within 3\u00a0years post\u2010index surgery in patients who had undergone extensive surgery at index (OR\u00a0=\u00a014.13, 95% CI 3.41\u201395.64) compared with those who had undergone limited surgery. OCS use was frequent among CRSwNP patients, with a higher cumulative dose in patients undergoing multiple ESS revisions (63%, <jats:italic>n<\/jats:italic>\u00a0=\u00a097, median daily dose 3.29\u00a0mg, IQR: 1.64\u20133.70) compared with patients without revisions (49%, <jats:italic>n<\/jats:italic>\u00a0=\u00a01361 and 1.64\u00a0mg, IQR: 1.64\u20133.29, respectively. <jats:italic>p<\/jats:italic>\u2010value &lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A small proportion of CRSwNP patients require revision ESS with associated high cumulative OCS doses, highlighting the need for additional therapies to achieve disease control and reduce the corticosteroid burden. A few simple baseline characteristics can predict the need for recurrent surgery among the patients with CRSwNP.<\/jats:p><\/jats:sec>","DOI":"10.1002\/clt2.70032","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T01:38:28Z","timestamp":1738201108000},"source":"Crossref","is-referenced-by-count":9,"title":["Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps"],"prefix":"10.1002","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-6686","authenticated-orcid":false,"given":"Sanna","family":"Toppila\u2010Salmi","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology University of Eastern Finland  Kuopio Finland"},{"name":"Department of Otorhinolaryngology Wellbeing Services County of Pohjois\u2010Savo  Kuopio Finland"},{"name":"Department of Allergology Inflammation Center Helsinki University Hospital and University of Helsinki  Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-1227","authenticated-orcid":false,"given":"Annina","family":"Lyly","sequence":"additional","affiliation":[{"name":"AstraZeneca Nordics Medical Affairs  Espoo Finland"},{"name":"AstraZeneca Nordics Medical and Regulatory  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-139X","authenticated-orcid":false,"given":"Johanna","family":"Simin","sequence":"additional","affiliation":[{"name":"Medaffcon Oy  Espoo Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4142-3256","authenticated-orcid":false,"given":"Juhani","family":"Aakko","sequence":"additional","affiliation":[{"name":"Medaffcon Oy  Espoo Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2043-5154","authenticated-orcid":false,"given":"Helga Haugom","family":"Olsen","sequence":"additional","affiliation":[{"name":"AstraZeneca Nordics Medical Affairs  Espoo Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1586-4998","authenticated-orcid":false,"given":"Lauri","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology Tampere University  Tampere Finland"},{"name":"Allergy Centre Tampere University Hospital  Tampere Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.10.010"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13411"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.04.012"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12200"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40463\u2010019\u20100350\u2010y"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/28.4.717"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348940311200709"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12181"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1324"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12472"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882\u2010015\u20100589\u2010y"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262\u2010022\u201001157\u20108"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2020.102654"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.27"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.523"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2017.31.4446"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22487"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020167"},{"key":"e_1_2_9_21_1","unstructured":"Nordic Medico\u2010Statistical Committee.Nomesco Classification of Surgical Procedures (NCSP).Nordic Centre for Classifications in Health Care."},{"key":"e_1_2_9_22_1","volume-title":"ATC\/DDD Index 2019","author":"WHO Collaborating Centre for Drug and Statistics Methodology","year":"2019"},{"key":"e_1_2_9_23_1","unstructured":"World Health Orgnization.Defined Daily Dose (DDD).https:\/\/www.who.int\/tools\/atc\u2010ddd\u2010toolkit\/about\u2010ddd"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021\u20109681(87)90171\u20108"},{"issue":"4","key":"e_1_2_9_26_1","first-page":"188","article-title":"Charlson comorbidity index: ICD\u20109 update and ICD\u201010 translation","volume":"12","author":"Glasheen WP","year":"2019","journal-title":"Am Health Drug Benefits"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10115\u2010013\u20100679\u2010x"},{"key":"e_1_2_9_28_1","unstructured":"GreenwellB.Fastshap: Fast Approximate Shapley Values.2021.https:\/\/CRAN.R\u2010project.org\/package=fastshap"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22505"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/coa.14070"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601\u2010019\u20100303\u20106"},{"key":"e_1_2_9_33_1","volume-title":"Suositus Biologisesta L\u00e4\u00e4kehoidosta","author":"Suomen Rinologiyhdistys","year":"2024"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2023.09.034"},{"key":"e_1_2_9_35_1","unstructured":"Dudecim Terveysportti.Pitkittynyt tai usein toistuva sivuontelotulehdus. L\u00e4\u00e4k\u00e4rin tietokannat.https:\/\/www.terveysportti.fi\/apps\/dtk\/ltk\/article\/ykt00990\/search\/nen%C3%A4polypoosi#s5"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S176026"},{"key":"e_1_2_9_37_1","unstructured":"Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis (WAYPOINT).https:\/\/clinicaltrials.gov\/study\/NCT04851964"},{"key":"e_1_2_9_38_1","unstructured":"Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID).https:\/\/clinicaltrials.gov\/study\/NCT04157335"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(19)31881\u20101"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20102600(21)00097\u20107"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/19458924211030486"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26169"}],"container-title":["Clinical and Translational Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clt2.70032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T01:58:53Z","timestamp":1741744733000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clt2.70032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1002\/clt2.70032"],"URL":"https:\/\/doi.org\/10.1002\/clt2.70032","archive":["Portico"],"relation":{},"ISSN":["2045-7022","2045-7022"],"issn-type":[{"value":"2045-7022","type":"print"},{"value":"2045-7022","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"article-number":"e70032"}}